|
|
|
|
|
|
by dfsegoat
1835 days ago
|
|
|
Per the article. The age group of concern "accounted for less than 9% of doses administered." Also, underreporting is a factor - not everyone knows about VAERS, not everyone goes to the Dr. for chest pain etc. I agree it's favorable, but it's important to understand the effects of any medicine on subgroups of a treatment population. |
|
|